Gamida Cell Ltd.(GMDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GMDA Gamida Cell Ltd.

Delisted 11-22 07:09:48 EST

0.0327

+0.0000

0.00%

High0.0327	Low0.0327	Vol0.00
Open0.0327	D1 Closing0.0327	Amplitude0.00%
Mkt Cap5.04M	Tradable Cap4.64M	Total Shares154.05M
T/O0.00	T/O Rate0.00%	Tradable Shares142.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"GMDA","market":"US","secType":"STK","nameCN":"Gamida Cell Ltd.","latestPrice":0.0327,"timestamp":1732222800000,"preClose":0.0327,"halted":4,"volume":0,"delay":0,"floatShares":142000000,"shares":154050953,"eps":-0.572433,"marketStatus":"Delisted","change":0,"latestTime":"11-22 07:09:48 EST","open":0.0327,"high":0.0327,"low":0.0327,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.572433,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1732285800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1540526400000,"exchange":"NASDAQ","adjPreClose":0.0327,"volumeRatio":0},"requestUrl":"/m/hq/s/GMDA/tweets","defaultTab":"tweets","newsList":[{"id":"2485825131","title":"BioLineRx, Ayrmid enter license agreement for motixafortide through Gamida Cell","url":"https://stock-news.laohu8.com/highlight/detail?id=2485825131","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485825131?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:35","pubTimestamp":1732275326,"startTime":"0","endTime":"0","summary":"Unlock your investing potential with TipRanks Premium - Now At 40% OFF!Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter. Bioline RX Ltd Sponsored ADR  Q3 Earnings Cheat Sheet. BioLineRx’s Motixafortide Shows Promise in Sickle Cell","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/c8pJ6Hc13EFaByQh6DEJ0A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/c8pJ6Hc13EFaByQh6DEJ0A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biolinerx-ayrmid-enter-license-agreement-113526432.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biolinerx-ayrmid-enter-license-agreement-113526432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BLRX","BK4139","GMDA"],"gpt_icon":0},{"id":"2453760334","title":"HOOKIPA Pharma Appoints Malte Peters CEO, Terry Coelho CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2453760334","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453760334?lang=en_us&edition=fundamental","pubTime":"2024-07-22 21:12","pubTimestamp":1721653928,"startTime":"0","endTime":"0","summary":"HOOKIPA Pharma  said Monday it has appointed Malte Peters as chief executive and Terry Coelho as chief financial officer of the company, effective immediately.Peters will succeed Joern Aldag, while Coelho will succeed Reinhard Kandera, HOOKIPA added. Aldag and Kandera will be leaving the company and stepping down from its board.Peters most recently served as chief research and development officer at MorphoSys , while Coelho most recently was the CFO of Gamida Cell , the company said. They both will continue to serve on the HOOKIPA's board.Price: 6.43, Change: +0.01, Percent Change: +0.16","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","MOR","BK4139","HOOK","GMDA"],"gpt_icon":0},{"id":"2453760313","title":"HOOKIPA Pharma Appoints Malte Peters CEO, Terry Coelho CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2453760313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453760313?lang=en_us&edition=fundamental","pubTime":"2024-07-22 21:12","pubTimestamp":1721653928,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["HOOK","GMDA","BK4139","MOR","BK4505"],"gpt_icon":0},{"id":"2453641347","title":"Press Release: HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200","url":"https://stock-news.laohu8.com/highlight/detail?id=2453641347","media":"Dow Jones","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453641347?lang=en_us&edition=fundamental","pubTime":"2024-07-22 20:30","pubTimestamp":1721651400,"startTime":"0","endTime":"0","summary":"-- Director Dr. Malte Peters named Chief Executive Officer and Director. Terry Coelho named Executive Vice President and Chief Financial Officer. -- Company is conducting a review of its business operations and strategy to. determine best path to create shareholder value and realize the full. Dr. Jan van de Winkel, Chairman of the Board, said: \"HOOKIPA has entered a critical new phase of its development for HB-200. The Company has received PRIME designation from the European Medicines Agency, reached alignment on a clinical development strategy with the U.S. Food and Drug Administration with a path to potential accelerated approval, and announced the pivotal Phase 2/3 trial design. The Company also continues to advance its other development programs, including those in collaboration with Gilead, with the first person recently dosed in the Phase 1b clinical trial of HB-500 for the treatment of HIV.The Company also announced that Sean Cassidy will join its Board of Directors, Audit Commi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMDA","BK4505","NQmain","TQQQ","BK4139",".IXIC","SQQQ","BK4007","QID","QLD","MNQmain","HOOK","ARVN","PSQ"],"gpt_icon":1},{"id":"2444480714","title":"BRIEF-Gamida Cell Appoints Joe Wiley As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2444480714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444480714?lang=en_us&edition=fundamental","pubTime":"2024-06-18 21:18","pubTimestamp":1718716730,"startTime":"0","endTime":"0","summary":"June 18 (Reuters) -    * GAMIDA CELL LTD - NAMED JOE WILEY AS CEO, RORY NEALON AS CFO, AND SHEILA FRAME AS CHIEF COMMERCIAL OFFICERSource text for Eikon:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMDA","BK4139"],"gpt_icon":0},{"id":"2444148486","title":"Gamida Cell Ltd - Named Joe Wiley as CEO, Rory Nealon as CFO, and Sheila Frame as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2444148486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444148486?lang=en_us&edition=fundamental","pubTime":"2024-06-18 20:17","pubTimestamp":1718713070,"startTime":"0","endTime":"0","summary":"Gamida Cell Ltd - Named Joe Wiley as CEO, Rory Nealon as CFO, and Sheila Frame as Chief Commercial Officer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240618:nFWN3IG028:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GMDA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gamida-cell.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.892},{"period":"ytd","weight":-0.9208}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.148003},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.012908},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.279964},{"month":4,"riseRate":0.333333,"avgChangeRate":0.080575},{"month":5,"riseRate":0.4,"avgChangeRate":0.063306},{"month":6,"riseRate":0,"avgChangeRate":-0.150827},{"month":7,"riseRate":0,"avgChangeRate":-0.180953},{"month":8,"riseRate":0.4,"avgChangeRate":0.075826},{"month":9,"riseRate":0.2,"avgChangeRate":-0.108316},{"month":10,"riseRate":0.8,"avgChangeRate":0.040304},{"month":11,"riseRate":0.5,"avgChangeRate":-0.004806},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.036686}],"exchange":"NASDAQ","name":"Gamida Cell Ltd.","nameEN":"Gamida Cell Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gamida Cell Ltd.(GMDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Gamida Cell Ltd.(GMDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Gamida Cell Ltd.,GMDA,Gamida Cell Ltd.股票,Gamida Cell Ltd.股票老虎,Gamida Cell Ltd.股票老虎国际,Gamida Cell Ltd.行情,Gamida Cell Ltd.股票行情,Gamida Cell Ltd.股价,Gamida Cell Ltd.股市,Gamida Cell Ltd.股票价格,Gamida Cell Ltd.股票交易,Gamida Cell Ltd.股票购买,Gamida Cell Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gamida Cell Ltd.(GMDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Gamida Cell Ltd.(GMDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction